Stock Events

Stock Events

Antigenics (CO) 

$0.000010
1
+$0.00+0%Monday 21:00

Statistics

Day High
0.000007
Day Low
0.000007
52W High
0.00001
52W Low
0.000007
Volume
3,000
Avg. Volume
0
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Moderna
MRNA
Mkt Cap88.52B
Moderna Inc. focuses on mRNA-based therapies, directly competing in the innovative vaccine and therapeutic segment similar to Antigenics.
BioNTech
BNTX
Mkt Cap22.15B
BioNTech SE develops and commercializes immunotherapies, a direct competitor in the field of personalized cancer vaccines and infectious disease vaccines.
Novavax
NVAX
Mkt Cap1.66B
Novavax, Inc. is involved in the development of vaccines for infectious diseases, competing in the same vaccine technology space as Antigenics.
Adaptive Biotechnologies
ADPT
Mkt Cap4.52B
Adaptive Biotechnologies Corp. works on immune-driven medicine, including the use of sequencing and bioinformatics to develop immunotherapies.
CRISPR Therapeutics
CRSP
Mkt Cap4.97B
CRISPR Therapeutics AG specializes in gene editing technology, which is pivotal for developing next-generation therapies in areas overlapping with Antigenics' interests.
Novartis
NVS
Mkt Cap303.67B
Novartis AG, through its advanced therapy platforms, competes in developing novel treatments in areas such as cancer, which may overlap with Antigenics' therapeutic vaccines.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences, Inc. is a biopharmaceutical company that develops drugs, including for oncology and infectious diseases, competing with Antigenics' research areas.
AMGEN
AMGN
Mkt Cap251.94B
Amgen Inc. is a biotech giant that develops innovative human therapeutics, including in oncology and immunology, areas relevant to Antigenics.
Regeneron Pharmaceuticals
REGN
Mkt Cap95.99B
Regeneron Pharmaceuticals, Inc. is known for its monoclonal antibodies and other biopharmaceuticals, competing in the immunotherapy space.
Pfizer
PFE
Mkt Cap173.95B
Pfizer Inc. develops and manufactures healthcare products, including vaccines and biopharmaceuticals for diseases that Antigenics also targets.

About

Antigenics, Inc., a clinical-stage biopharmaceutical company, discovers, manufactures, and develops immunotherapies for cancer. The company was founded in 1994 and is based in Lexington, Massachusetts.
Show More
CEO
Garo Armen
Country
United States
ISIN
US0370311013

Listings

OTCM
US
ANTI
OTC Link
US
ATGC

0 Comments

Share your thoughts

FAQs

What is Antigenics (CO) stock price today?▼
The current price of ANTI is $0.00 USD — it has increased by +0% in the past 24 hours. Watch Antigenics (CO) stock price performance more closely on the chart.
What is Antigenics (CO) stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTCM exchange Antigenics (CO) stocks are traded under the ticker ANTI.
Is Antigenics (CO) stock price growing?▼
ANTI stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Antigenics (CO) has showed a +0% increase.
In which sector is Antigenics (CO) located?▼
Antigenics (CO) operates in the Health & Wellness sector.
When did Antigenics (CO) complete a stock split?▼
Antigenics (CO) has not had any recent stock splits.
Where is Antigenics (CO) headquartered?▼
Antigenics (CO) is headquartered in Lexington, United States.